Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NATI
401
DELISTED
National Instruments Corp
NATI
| $91.2M | 0.05% |
1,589,403
+388,737
| +32% | +$22.3M |
|
402
Lantheus
LNTH
$6.53B
| $91.2M | 0.05% |
1,087,091
+838,567
| +337% | +$75.2M |
|
403
Centene
CNC
$32.1B
| $90.8M | 0.04% |
1,346,014
-902,955
| -40% | -$60.2M |
|
404
Weatherford International
WFRD
$6.49B
| $90.4M | 0.04% |
1,360,743
-494,886
| -27% | -$30.5M |
|
405
CALL
Merck
MRK
$376B
| $90.4M | 0.04% |
783,200
+523,200
| +201% | +$59.4M |
|
406
WillScot Mobile Mini Holdings
WSC
$4.01B
| $90.3M | 0.04% |
1,889,935
+983,180
| +108% | +$44M |
|
407
CALL
IBM
IBM
$222B
| $90.2M | 0.04% |
674,200
-84,400
| -11% | -$10.9M |
|
408
UnitedHealth
UNH
$350B
| $89.9M | 0.04% |
187,062
-165,747
| -47% | -$81M |
|
409
Emcor
EME
$34.3B
| $89.8M | 0.04% |
485,828
-29,772
| -6% | -$4.98M |
|
|
MRSH
410
Marsh
MRSH
$91.6B
| $89.7M | 0.04% |
476,698
-228,405
| -32% | -$40.5M |
|
|
FITB
411
Fifth Third Bancorp
FITB
$49.7B
| $89M | 0.04% |
3,394,218
-333,649
| -9% | -$8.6M |
|
412
Boeing
BA
$169B
| $88.9M | 0.04% |
421,015
-183,917
| -30% | -$38.2M |
|
413
Houlihan Lokey
HLI
$9.02B
| $88.7M | 0.04% |
902,664
+869,953
| +2,660% | +$78.7M |
|
414
Mondelez International
MDLZ
$82.3B
| $88.3M | 0.04% |
1,211,084
-313,316
| -21% | -$23.1M |
|
415
Otis Worldwide
OTIS
$27.2B
| $88.1M | 0.04% |
989,784
+984,003
| +17,021% | +$82.9M |
|
416
Qiagen
QGEN
$9.1B
| $88.1M | 0.04% |
1,844,244
+1,527,341
| +482% | +$73.6M |
|
417
Dick's Sporting Goods
DKS
$16.4B
| $88M | 0.04% |
665,773
-2,827
| -0.4% | -$387K |
|
418
Cenovus Energy
CVE
$60.7B
| $87.8M | 0.04% |
+5,168,367
| New | +$87.1M |
|
|
AVDX
419
DELISTED
AvidXchange
AVDX
| $87.4M | 0.04% |
8,417,922
+329,355
| +4% | +$2.96M |
|
420
Guardant Health
GH
$22.9B
| $87.1M | 0.04% |
2,434,178
+1,136,756
| +88% | +$32.6M |
|
421
CALL
Honeywell
HON
$68.4B
| $87.1M | 0.04% |
445,408
+126,153
| +40% | +$23.4M |
|
422
Penumbra
PEN
$12.8B
| $86.9M | 0.04% |
252,662
+51,522
| +26% | +$15.8M |
|
423
PUT
Johnson & Johnson
JNJ
$651B
| $86.7M | 0.04% |
524,000
+345,300
| +193% | +$55.7M |
|
424
Travelers Companies
TRV
$75.8B
| $86.6M | 0.04% |
498,909
+167,446
| +51% | +$29.5M |
|
425
Golar LNG
GLNG
$5.31B
| $86.6M | 0.04% |
4,295,123
-818,185
| -16% | -$17.6M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.